Nair S, Samy T S, Krishan A
Cancer Res. 1986 Jan;46(1):229-32.
Anticalmodulin and calcium channel blockers have been shown to reverse Adriamycin resistance by reducing the drug efflux from resistant cells. Since cellular calcium and calmodulin levels are probably related to these effects, we have measured the total, membrane-bound, and intracellular calcium levels in Adriamycin-resistant (P388/R) and -sensitive (P388/S) leukemia cells. In P388/R cells, total calcium was approximately 1.4-fold higher than that of P388/S cells. Membrane-bound and intracellular calcium levels were also higher in P388/R cells. No major difference was observed in the calmodulin content of these cells. The P388/R cells had a higher (approximately 1.4-fold) protein content. When calculated on the basis of per unit protein, P388/S and P388/R cells had similar total calcium but a higher intracellular free calcium and calmodulin content in P388/S cells. Thus our studies suggested that the lower drug efflux and increased drug retention in P388/R cells may not be related to calcium and calmodulin levels but may be due to some other membrane-related factors.
抗钙调蛋白和钙通道阻滞剂已被证明可通过减少耐药细胞中的药物外排来逆转阿霉素耐药性。由于细胞内钙和钙调蛋白水平可能与这些作用有关,我们测量了阿霉素耐药(P388/R)和敏感(P388/S)白血病细胞中的总钙、膜结合钙和细胞内钙水平。在P388/R细胞中,总钙比P388/S细胞高约1.4倍。P388/R细胞中的膜结合钙和细胞内钙水平也更高。这些细胞的钙调蛋白含量未观察到重大差异。P388/R细胞的蛋白质含量更高(约1.4倍)。以每单位蛋白质计算时,P388/S和P388/R细胞的总钙相似,但P388/S细胞的细胞内游离钙和钙调蛋白含量更高。因此,我们的研究表明,P388/R细胞中较低的药物外排和增加的药物滞留可能与钙和钙调蛋白水平无关,而可能是由于其他一些与膜相关的因素。